CC-5013-13C5 - Names and Identifiers
CC-5013-13C5 - Physico-chemical Properties
Molecular Formula | C13H13N3O3
|
Molar Mass | 264.30562 |
Melting Point | 248-250°C |
Solubility | DMSO (Slightly), Methanol (Very Slightly) |
Appearance | Solid |
Color | Pale Yellow to Light Yellow |
Storage Condition | -20°C Freezer, Under Inert Atmosphere |
CC-5013-13C5 - Introduction
rac Lenalidomide-13C5 is a rac Lenalidomide containing 13C isotopes. Lenalidomide is an oral immunomodulator used to treat multiple myeloma and certain disease-related myelodysplastic syndromes. Its mechanism of action is mainly to inhibit tumor growth by regulating the immune system and improving cell signal transduction.
The preparation method of rac Lenalidomide-13C5 can be realized by synthesis. Specific preparation methods may involve organic synthesis reactions and isotopic labeling techniques.
The safety of the compound is generally good, but it is still necessary to follow the doctor's guidance and medication precautions. Common adverse reactions include anemia, leukopenia, thrombocytopenia, infection and so on. Hematological indicators should be monitored regularly during use, and the risk of pregnancy and malformations should be avoided. Please read the instructions carefully and consult a doctor before use. It should be used under clinical monitoring if necessary.
Last Update:2024-04-09 02:00:54